NCT01978132View on ClinicalTrials.gov

Primary Hyperaldosteronism and Ischemia-reperfusion Injury

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 1, 2017

Study Completion Date

July 1, 2017

Conditions
Primary Hyperaldosteronism
Interventions
PROCEDURE

forearm ischemia and reperfusion

both arms will be subjected to 20 minutes of forearm ischemia and 20 minutes of reperfusion.

Trial Locations (1)

6525EZ

Radboud University Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01978132 - Primary Hyperaldosteronism and Ischemia-reperfusion Injury | Biotech Hunter | Biotech Hunter